Skip to main content
. Author manuscript; available in PMC: 2020 Jun 29.
Published in final edited form as: Lancet Diabetes Endocrinol. 2018 Oct 24;7(1):52–64. doi: 10.1016/S2213-8587(18)30112-8

Figure 2. Considerations to improve T1D immune therapy trials.

Figure 2.

Implementing these eight notions may accelerate identification of effective immune therapies for T1D and application in clinical settings.